Commitment to Access, Quality and Growth through Innovation

Nov. 4, 2019

Dynacare Launches JOINTstat® Testing in Canada

Augurex is pleased to announce the launch of JOINTstat (14-3-3?) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support healthy lives with commitment and care. This arrangement will make JOINTstat testing accessible to more patients and physicians across Canada. Read More

Augurex Commitment to Quality: ISO 13485:2016

Augurex is proud to announce its ISO 13485:2016 Certification. Whether it’s in administration, accounting or product design & manufacturing, Augurex is committed to quality processes that create a solid foundation for our commercialized products, scientific collaborations and pipeline biomarker development.

Schedule your meeting with Augurex today

Join Augurex with the global rheumatology community and learn about cutting edge research and biomarker science at the ACR/ARHP Annual Meeting. We look forward to meeting with many of you in Atlanta to provide an update on the 14-3-3η (JOINTstat) biomarker and pipeline products. If you would like to schedule a meeting with an Augurex team member, click the “Schedule Now” button

Commitment to Access, Quality and Growth through Innovation

Contact supplier

Stay in the loop!